E71.50

Clinical Causes: Genetic mutations: Peroxisomal disorders are inherited in an autosomal recessive manner, meaning a person needs to inherit two copies of the affected gene—one from each parent. Mutations affecting peroxisomal biogenesis: These mutations disrupt the formation and function of peroxisomes, leading to a buildup of harmful substances in cells. Enzyme deficiencies: Some peroxisomal disorders result from the lack of specific enzymes necessary for fat metabolism. Unknown factors: In some cases, the exact genetic or environmental cause remains unclear, leading to an 'unspecified' classification.

Key Symptoms: Developmental delays or intellectual disability Muscle weakness or hypotonia Seizures Vision problems, such as cataracts or retinal abnormalities Liver enlargement or dysfunction Poor feeding or failure to thrive in infants Distinctive facial features in some cases Progressive neurological deterioration Speech and language delays Thermal regulation issues, like difficulty tolerating temperature changes

Diagnosis Path: Diagnosing a peroxisomal disorder involves a combination of clinical evaluation, blood tests, and genetic studies. Specific tests may include measuring levels of related enzymes or metabolites in blood or tissues, neuroimaging such as MRI scans to observe brain abnormalities, and genetic sequencing to identify mutations. Since the ICD-10 code indicates an unspecified condition, further testing may be necessary to clarify the exact nature of the disorder.

Treatment Protocols: Currently, there is no cure for peroxisomal disorders. Management focuses on alleviating symptoms and preventing complications. Treatment strategies may include nutritional support, medications to control seizures or other neurological symptoms, and physical or occupational therapy to improve mobility and function. Regular monitoring by a multidisciplinary team is essential to address evolving health concerns and improve quality of life.